Hyposmia, the reduced ability to smell, is very common in Parkinson?s disease (PD). Almost 90% of PD patients have hyposmia, which often develops about a decade before motor symptoms manifest. The pathology of PD is characterized by the presence of aggregated ?-synuclein in neurons across the brain; ?-Synuclein aggregation is believed to start in the olfactory brain regions, especially the olfactory bulb, and then spreads to other structures in the brain. The manifestation of the symptoms in PD is therefore believed to reflect the spreading of the pathology, explaining why olfactory deficits would manifest before other symptoms. In addition to ?-synuclein aggregation, there are other key processes that normally associate with PD ? neuronal death and neuroinflammation. There is, however, a fundamental gap in knowledge regarding the pathogenic mechanisms which cause hyposmia in PD. Thus, the objective of this multi-PI project is to establish how the progressive spreading of aggregated ?-synuclein from the olfactory bulb to other olfactory structures, and the associated neural cell death and neuroinflammation, trigger hyposmia. To this end, we will perform sophisticated measures of olfactory function (Wesson) in an experimental paradigm that we recently developed and which recreates spreading of ?-synuclein pathology across olfactory structures associated with olfactory deficits (Brundin). With this approach we will define the links between olfactory dysfunction and key underlying mechanisms of early PD, testing the hypothesis that ?- synuclein pathology progression from the olfactory bulb induces widespread neurodegeneration, protein aggregation, and neuroinflammation in the olfactory system, resulting in impaired olfaction. Specifically, we aim to demonstrate that ?-synuclein pathology affects odor information processing and to identify neuropathological underpinnings of these olfactory deficits. Further, we will test innovative approaches to modulate pathogenesis and to determine whether these interventions can improve olfactory function and/or stop the spreading of the pathology. These findings will provide fundamental information on the olfactory system and on how olfaction is impacted by specific neurodegenerative processes. We expect that our findings will eventually facilitate the development of therapeutic approaches to prevent the development of olfactory deficits associated with the spreading of ?-synuclein pathology across olfactory structures. Since these therapies should also prevent the spreading of ?- synuclein pathology to other brain regions, they have the potential to become disease-modifying interventions against PD.
The proposed research is relevant to public health because understanding the mechanisms underlying olfactory dysfunction in the context of neurodegenerative disease would lay the basis for the development of therapeutic strategies that could prevent its development. The proposed research is relevant to the missions of NIH and NIDCD because it aims to generate knowledge that could be used to prevent olfactory dysfunction or even stop the progression of neurodegenerative diseases, reducing the very significant economic burden that they represent.
| Rey, Nolwen L; Wesson, Daniel W; Brundin, Patrik (2018) The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis 109:226-248 |
| Steiner, Jennifer A; Quansah, Emmanuel; Brundin, Patrik (2018) The concept of alpha-synuclein as a prion-like protein: ten years after. Cell Tissue Res 373:161-173 |
| Rey, Nolwen L; George, Sonia; Steiner, Jennifer A et al. (2018) Spread of aggregates after olfactory bulb injection of ?-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65-83 |
| Killinger, Bryan A; Madaj, Zachary; Sikora, Jacek W et al. (2018) The vermiform appendix impacts the risk of developing Parkinson's disease. Sci Transl Med 10: |
| Brundin, Patrik; Dave, Kuldip D; Kordower, Jeffrey H (2017) Therapeutic approaches to target alpha-synuclein pathology. Exp Neurol 298:225-235 |
| Labrie, Viviane; Brundin, Patrik (2017) Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection. J Innate Immun 9:437-440 |
| Brundin, Patrik; Melki, Ronald (2017) Prying into the Prion Hypothesis for Parkinson's Disease. J Neurosci 37:9808-9818 |
| Thirtamara-Rajamani, Keerthi; Li, Peipei; Escobar Galvis, Martha L et al. (2017) Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease? J Parkinsons Dis 7:577-587 |
